Reade Rheumatology Research Institute
4 clinical trials · Sponsor
◉ Watch Reade Rheumatology Research Institute
| Record | Firm | Date |
|---|---|---|
| Use of Tocilizumab Drug Levels to Optimize Treatment in RA (NCT03895879) | Reade Rheumatology Research Institute | 2020-03-01 |
| Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring (NCT04194827) | Reade Rheumatology Research Institute | 2020-03-01 |
| Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease Activity (NCT04222920) | Reade Rheumatology Research Institute | 2020-03-01 |
Track Reade Rheumatology Research Institute automatically
Every clearance here is in the API, with alerts when new ones post.